Expedeon
Expert in cutting-edge innovative reagents and services for life sciences and diagnostics.
Financials
Estimates*
EUR | 2017 | 2018 |
---|---|---|
Revenues | 5.0m | <1m |
% growth | - | (86 %) |
EBITDA | 1.0m | (<1m) |
% EBITDA margin | 20 % | (11 %) |
Profit | 5.0m | <1m |
% profit margin | 100 % | 86 % |
Date | Investors | Amount | Round |
---|---|---|---|
£240k | Early VC | ||
$6.5m | Debt | ||
* | €120m | Acquisition | |
Total Funding | €288k |
Recent News about Expedeon
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Expedeon
EditACQUISITION by Expedeon Nov 2011